Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pt (II) complex with photodynamic tri-negative breast cancer resisting activity as well as preparation method and application of Pt (II) complex

A technology of triple-negative breast cancer and complexes, applied in the field of medicine, to achieve strong inhibitory effects, overcome drug resistance and side effects

Pending Publication Date: 2021-12-28
HUBEI UNIV OF SCI & TECH
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the application of platinum-based antineoplastic drugs is limited. There are two main reasons: (1) the side effects are more obvious, including nephrotoxicity, neurotoxicity, bone marrow suppression, nausea, vomiting, hair loss and fatigue; Drug resistance is prominent, including endogenous drug resistance and acquired drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pt (II) complex with photodynamic tri-negative breast cancer resisting activity as well as preparation method and application of Pt (II) complex
  • Pt (II) complex with photodynamic tri-negative breast cancer resisting activity as well as preparation method and application of Pt (II) complex
  • Pt (II) complex with photodynamic tri-negative breast cancer resisting activity as well as preparation method and application of Pt (II) complex

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047]Preparation of PT (II) complexes with the following structural formula and its reference (BC-PT complex):

[0048]

[0049] The synthesis route of the PT (II) complex and its reference (BC-PT complex) is as follows:

[0050]

[0051] Among them, r = h or i.

[0052] Specifically, include the following steps:

[0053] 1) The 2,4-dimethylpyrrole (2.00 g, 21 mmol) was dissolved in dichloromethane (150 mL). Under nitrogen protection, 4-chlorocanoyl chloride (1.48 g, 10.5 mmol) was added, and stirred at 25 ° C for 5 min, stirred at 50 ° C for 2 h, cooled to room temperature, vacuum evaporation, residue with toluene (150 ml) and dichlorchloro Methane (25 mL) was dissolved, 5 min, triethylamine (2.53 g, 25 mmol) was added to the reaction mixture, and stirring was stirred at normal temperature for 15 min. In n 2 Under protection, slow add BF 3 · ET 2 O (7.60g, 50 mmol). Thereafter, the magnetic stirring reaction was continued at 50 ° C for 1 h. The solvent was evaporated to room...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of research and development of anti-cancer drugs, and particularly relates to a Pt (II) complex with photodynamic tri-negative breast cancer resisting activity and a preparation method and application thereof. According to the invention, iodo-BODIPY with excellent photosensitive activity is used as a photosensitive group, DPA (dimethylamine pyridine) is used as a Pt (II) coordination group, and the Pt (II) complex with photodynamic activity is creatively designed and synthesized. The Pt (II) complex belongs to a novel compound, shows excellent in-vitro tri-negative breast cancer resisting activity, has potential medicinal value and is expected to be used for preparing various tri-negative breast cancer resisting drugs. The structural formula of the Pt (II) complex is as shown in the specification.

Description

Technical field [0001] The present invention belongs to the field of medical technology, particularly relates to an anti TNBC activity Pt (Ⅱ) complex and its preparation method and application of light having a power. Background technique [0002] Breast cancer is a common malignancy in women, breast cancer is the so-called triple-negative breast cancer surgical pathology specimens immunohistochemical monitoring estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER- 2) these three indicators are negative breast cancer, it is a special type of malignant breast cancer. The clinical features of Chinese people TNBC, mainly as follows: (1) mostly younger patients; (2) large mass; (3) lymph node metastasis rate; (4) there is a family history of breast cancer. Breast cancer is a hormone-dependent tumors, endocrine therapy is a primary treatment, because of its triple-negative breast cancer hormone receptor were negative, therefore, the lack o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07F15/00A61P35/00
CPCC07F15/0093A61P35/00Y02A50/30
Inventor 王小波王淑平王宇静方霄
Owner HUBEI UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products